Urban Malaria and India's Elimination Goal
The spread of the invasive vector Anopheles stephensi in metropolitan areas, such as Delhi, has become a significant challenge to India's aim of eradicating malaria by 2030, as per the Health Ministry’s Malaria Elimination Technical Report, 2025.
Challenges in Malaria Elimination
- Persistent transmission due to:
- Asymptomatic infections
- Difficult terrain
- Population movement
- High-burden pockets in districts of Odisha, Tripura, and Mizoram.
- Cross-border transmission from Myanmar and Bangladesh affects northeastern border districts.
Goals and Strategies
- India aims for zero indigenous cases by 2027, aligning with WHO's global strategy.
- Anopheles stephensi thrives in urban settings, breeding in artificial containers and efficiently transmitting Plasmodium parasites.
- Necessity for city-specific vector control and surveillance strategies due to:
- Container breeding
- Construction sites
- High population density
- Fragmented healthcare delivery
Current Status and Priorities
India is in the pre-elimination phase of malaria, with the disease no longer uniformly distributed, but concentrated in specific pockets.
- Priority strategies include strengthening surveillance, enhancing vector monitoring, and improving supply chain reliability.
- Active surveillance intensified in tribal, forest areas, border regions, and migratory settings.
Progress and Challenges
- Malaria cases in India have reduced from 11.7 lakh in 2015 to approximately 2.27 lakh in 2024, with a 78% reduction in deaths.
- Challenges include:
- Inconsistent private-sector reporting
- Limited entomological capacity
- Drug and insecticide resistance
- Operational gaps in remote tribal areas
- Sporadic shortages of diagnostics and treatment commodities
Research and Development
Operational research is crucial for accelerating elimination, focusing on areas such as:
- Asymptomatic infections
- Anopheles stephensi ecology and control
- Drug and insecticide resistance
- Optimization of treatment regimes for P. vivax